Enter your login e-mail to the account
Search
- Intrathecal synthesis of specific antiviral antibodies in relapsing-remitting and primary chronic progressive courses of multiple sclerosis
doc. MUDr. Pavel Štourač, Ph.D., MUDr. Jana Bednářová, Ph.D.
(5/2009, Main topic ) - Experience with shortened ocrelizumab infusion – ENSEMBLE PLUS study
doc. MUDr. Yvonne Benešová, Ph.D.
(1/2022, Review articles ) - Central nervous system vasculitis
MUDr. Aleš Tomek, Ph.D., FESO
(6/2015, Main topic ) - Anti CD20 multiple sclerosis therapy
Doc. MUDr. Pavel Štourač, Ph.D.
(1/2018, Pharmacotherapy ) - The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - Current role of evoked potentials in multiple sclerosis diagnostics and monitoring
MUDr. Václav Boček, Ph.D.
(2/2021, Review articles ) - Errors and mistakes in diagnosing multiple sclerosis
MUDr. Jiří Piťha
(3/2015, Review articles ) - Ocrelizumab – pharmacoloical profile
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(5/2018, Pharmacotherapy ) - Importance of early diagnosis and treatment in the life perspective of patients with multiple sclerosis
doc. MUDr. Jan Mareš, Ph.D.
(5/2012, Review articles ) - Monoklonální protilátky v léčbě roztroušené sklerózy
MUDr. Marek Peterka , MUDr. Zdeněk Kasl, Ph.D.
(2/2018, Pharmacotherapy ) - Long-term data of multiple sclerosis treatment with ocrelizumab – eficacy, safety and clinical experience
MUDr. Mgr. Matouš Rous, MUDr. Zuzana Rous, Ph.D.
(6/2021, Review articles ) - Treatment persistence to ocrelizumab and local experience
MUDr. Simona Halúsková, prof. MUDr. Martin Vališ, Ph.D., FEAN
(3/2021, Review articles ) - B cells as a target in the treatment of multiple sclerosis
MUDr. Luděk Hochmuth
(3/2017, Review articles ) - Late Lyme neuroborreliosis or post-Lyme borreliosis syndrome? A case report
MUDr. Ladislav Gurčík, PhD.
(6/2010, Case reports ) - Longterm safety of Ocrelizumab in Multiple Sclerosis treatment
MUDr. Marek Peterka , MUDr. Pavel Potužník
(4/2020, Review articles ) - Primary progressive multiple sclerosis – diagnosis, clinical aspects and treatment
MUDr. Ladislav Gurčík, PhD.
(5/2011, Review articles ) - Cesta ke spolehlivé diagnostice roztroušené sklerózy
MUDr. Radomír Taláb, CSc.
(4/2008, Main topic ) - Léčba progresivní roztroušené sklerózy
MUDr. Ivana Kovářová
(4/2008, Main topic ) - Ocrelizumab v léčbě roztroušené sklerózy
Prof. MUDr. Eva Kubala Havrdová, CSc.
(4/2017, Pharmacotherapy ) - B‑ lymphocyte‑ targeted MS therapy: from theory to a decade of ocrelizumab in practice
MUDr. Dominika Šťastná, Ph.D., MUDr. Jana Seňavová, prof. MUDr. Dana Horáková, Ph.D.
(2/2024, Review articles ) - The influence on long-term progression of multiple sclerosis – brighter days ahead?
MUDr. Dominika Šťastná, doc. MUDr. Dana Horáková, Ph.D.
(1/2021, Review articles ) - Ocrelizumab and novel therapeutic goals in multiple sclerosis
MUDr. Radek Ampapa
(2/2020, Review articles )
- HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMOPOIETIC CELL TRANSPLANTATION
MUDr. Ján Gyárfáš
(5/2008, Review articles )
- Chronic cerebrospinal venous insufficiency and its controversial relationship with multiple sclerosis
MUDr. Juraj Maďarič, PhD., MPH, MUDr. Ivan Vulev, PhD., MPH, FCIRSE
(1/2014, Main topic )
- SPG7 and multiple sclerosis: the hidden boundary between autoimmunity and hereditary neuropathy
Mgr. Lucie Fialová, PhD., Mgr. Magdaléna Mičulková Dvořáková, MUDr. Andrea Hladíková, Ph.D., MUDr. Michal Březík, FEBO, Bc. Monika Kudrejová, prim. MUDr. Dagmar Grečmalová
(1/2025, Case reports )